QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 发表日期：2017    内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Comparison of efficacy and safety of first-line palliative chemotherapy with TX and XELOX regimens in patients with metastatic gastric adenocarcinoma: A randomized phase II trial. 会议论文 作者:  Zhu, Xiaodong;  Li, Jin;  Zhao Xiaoying;  Guo, Weijian;  Liu, Xin 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文 作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer 会议论文 作者:  Fizazi, Karim;  Tran, Namphuong;  Fein, Luis Enrique;  Matsubara, Nobuaki;  Antolin, Alfredo Rodriguez 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare). 会议论文 作者:  Zhu, Ji;  Sun, Xinchen;  Zhang, Tao;  Liu, Anwen;  Zhu, Yuan 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer. 会议论文 作者:  Fizazi, Karim;  Namphuong Tran;  Enrique Fein, Luis;  Matsubara, Nobuaki;  Rodriguez Antolin, Alfredo 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05 A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04 A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating m 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Huober, Jens Bodo;  Holmes, Eileen McCormick;  Baselga, Jose;  De Azambuja, Evandro;  Untch, Michael 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04